OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazole–Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation
Ashok Babu Kasetti, Indrajeet Singhvi, Ravindra Nagasuri, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2847-2847
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 67

Synthesis and Pharmacological Activities of Chalcone and Its Derivatives Bearing N-Heterocyclic Scaffolds: A Review
Kibrom Mezgebe, Yadessa Melaku, Endale Mulugeta
ACS Omega (2023) Vol. 8, Iss. 22, pp. 19194-19211
Open Access | Times Cited: 47

Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
Richie R. Bhandare, Chandrashekar Suradhenupura Munikrishnappa, G.V. Suresh Kumar, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 3, pp. 101447-101447
Open Access | Times Cited: 38

A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 20

Development of Orally Active Anti-Inflammatory Agents: In Vivo and In Silico Analysis of Naphthalene-Chalcone Derivatives Based on 2-Acetyl-6-Methoxy Naphthalene
D Vasudha, A Jagadeesh, Sathish Kumar Konidala, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100472-100472
Open Access | Times Cited: 7

Synthesis and biological evaluation of novel [1,2,3]triazolo-pyrrolo[1,2-a]pyrido[4,3-d]pyrimidines as EGFR targeting anticancer agents
Sandhya Rani Bandi, Natte Kavitha, Satheesh Kumar Nukala, et al.
Journal of Molecular Structure (2022) Vol. 1274, pp. 134378-134378
Closed Access | Times Cited: 28

Design, synthesis and docking studies of new hydrazinyl-thiazole derivatives as anticancer and antimicrobial agents
Abeer M. El‐Naggar, Alaa Zidan, Eslam B. Elkaeed, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 4, pp. 101488-101488
Open Access | Times Cited: 25

2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies
B. Sivakumar, Sankaranarayanan Murugesan, Beutline Malgija, et al.
ACS Omega (2023) Vol. 8, Iss. 46, pp. 44287-44311
Open Access | Times Cited: 11

Synthesis, molecular docking and pharmacological evaluations of novel naphthalene-pyrazoline hybrids as new orally active anti-inflammatory agents
D Vasudha, A Jagadeesh, Suraj N. Mali, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100500-100500
Open Access | Times Cited: 3

Antitubercular and antioxidant activities of hydroxy and chloro substituted chalcone analogues: Synthesis, biological and computational studies
Shaik Ammaji, Shaik Masthanamma, Richie R. Bhandare, et al.
Arabian Journal of Chemistry (2021) Vol. 15, Iss. 2, pp. 103581-103581
Open Access | Times Cited: 28

Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10

Synthesis of Quinoline‐Thiazolidine‐2,4‐dione Coupled Pyrazoles as in vitro EGFR Targeting Anti‐Breast Cancer Agents and Their in silico Studies
Mallikarjuna Bangaru, Satheesh Kumar Nukala, Praveen kumar Kannekanti, et al.
ChemistrySelect (2023) Vol. 8, Iss. 12
Closed Access | Times Cited: 10

Modulators targeting protein-protein interactions in Mycobacterium tuberculosis
Guo‐Feng Luo, Tianqi Ming, Yang Luchuan, et al.
Microbiological Research (2024) Vol. 284, pp. 127675-127675
Closed Access | Times Cited: 3

Novel 1,2,3-triazole-aurone hybrids as cathepsin B inhibitors: One-pot synthesis, anti-proliferative, and drug modeling studies
Bhavna Saroha, Gourav Kumar, Suresh Kumar, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 12

Advances in chalcone derivatives: Unravelling their anticancer potential through structure-activity studies
Khursheed Ahmad Sheikh, Amisha Gupta, Mohammad Faisal Umar, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137154-137154
Closed Access | Times Cited: 6

Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents: in vitro, cytotoxicity assessment and in silico
L. S. Dhivya, Kathiravan Muthu Kumaradoss
Future Medicinal Chemistry (2023) Vol. 15, Iss. 18, pp. 1687-1701
Closed Access | Times Cited: 5

A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity
Anjaneyulu Bendi, Priyanka Yadav, Komal Saini, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 1

Drugs and Their Mode of Action: A Review on Sulfur-Containing Heterocyclic Compounds
Kanchan Kapoor, Navneet Kaur, Harvinder Singh Sohal, et al.
Polycyclic aromatic compounds (2024), pp. 1-40
Closed Access | Times Cited: 1

Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives
Shefali Chowdhary, Preeti Preeti, Shekhar Shekhar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1

Synthetic approaches for novel fused pyrimidine derivatives: design, structural characterization, antiviral, antitumor, and molecular docking evaluation
Fatmah O. Sefrji, Abdulmajeed F. Alrefaei, Mohammed A Imam, et al.
Heliyon (2024) Vol. 10, Iss. 24, pp. e40903-e40903
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top